To Read The Full Story
Continue reading your article with a Membership
Counsel
Alnylam was represented by a team at McDermott Will & Emery LLP: Ethan Haller Townsend, Anisa K. Noorassa, Bhanu K. Sadasivan, Ian B. Brooks, Sarah Chapin Columbia, Sarah J. Fischer, Timothy M. Dunker, and William G. Gaede.
Meanwhile, Moderna was represented by Farnan LLP’s Michael J. Farnan and Brian E. Farnan, as well as Cooley’s Angela R. Madrigal, Brianna (Chamberlin) Patterson, Dean Fanelli, Elizabeth M. Flanagan, Elizabeth L. Stameshkin, Geoffrey D. Biegler, and William Chad Shear.
Alnylam v. Pfizer/BioNTech
Alnylam is also suing Pfizer and BioNTech over the alleged infringement of five of its LNP patents in the District of Delaware. In May, the company withdrew its opposition to Pfizer and BioNTech’s motion for summary judgment, after an opinion by Judge Colm Connolly of the United States District Court for the District of Delaware interpreted the company’s patents in a way that would not cover Pfizer and BioNTech’s vaccine (May 15, 2025 ip fray article). And, marking another huge loss for Alnylam, the district court held in July that the defendants’ COVID-19 vaccine did not infringe any of Alnylam’s asserted patents (July 30, 2025 final order).